COMPASS Pathways plc
CMPS
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited anā¦ read more
Healthcare
Medical Care Facilities
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.37
Price+2.58%
$0.16
1Y
Price
Market Cap
$611.533m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$0.00
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$237.316m
-53.0%
1y CAGR-37.8%
3y CAGR-35.2%
5y CAGREPS
-$2.72
-18.3%
1y CAGR-8.3%
3y CAGR-11.4%
5y CAGRBook Value
$37.591m
$255.607m
Assets$218.016m
Liabilities$35.184m
DebtDebt to Assets
13.8%
-0.1x
Debt to EBITDAFree Cash Flow
-$161.209m
-35.3%
1y CAGR-16.5%
3y CAGR-26.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company